We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: New EMBL-led research identifies a robust gut microbiome signature linked to colorectal cancer, consistent across populations, sequencing methods & age groups, and tied to lower dietary fiber intake. (Photo courtesy of Daniela Velasco/EMBL)

Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer

An AI approach integrates diverse sequencing data to identify a reproducible colorectal cancer microbiome signature. More...
26 Jun 2026
Image: The HepQuant SHUNT Liver Diagnostic Test assesses chronic liver disease physiology by measuring  clearances of intravenously administered cholate and orally administered cholate that reflect liver blood flow and hepatocyte function (Image credit: iStock)

FDA-Approved Test Identifies Low Risk of Large Esophageal Varices in Cirrhosis

A new test quantifies risk of large esophageal varices in compensated cirrhosis, helping avoid unnecessary endoscopy. More...
26 Jun 2026
Image: Researchers reveal that in Sjögren disease, an autoimmune disease, not only immune cells but also the fibroblasts that make up the tissue are actively involved in the progression of the disease. CD153+ CD4+ T cells interact with CD30+ fibroblasts in primary Sjögren disease, amplifying inflammation and tissue damage. This pathological cellular interaction represents a potential therapeutic target for autoimmune Sjögren disease. (Photo courtesy of Professor Koji Yasutomo, Tokushima University, Japan)

New Cellular Biomarkers Correlate with Disease Severity in Sjögren Disease

New findings reveal an immune-fibroblast pathway in primary Sjögren disease that may serve as a novel biomarker for diagnosis or monitoring. More...
26 Jun 2026
Image: a new initiative aims to bring greater precision to this class of therapeutics (Photo courtesy of One Biosciences)

Project Aims to Develop First Single-Cell Assay for ADC Therapies

One Biosciences receives Paris Saclay Cancer Cluster BOOST funding to advance a single-cell assay approach for antibody-drug conjugate therapies. More...
26 Jun 2026
Image: a new initiative aims to bring greater precision to this class of therapeutics (Photo courtesy of One Biosciences)

Project Aims to Develop First Single-Cell Assay for ADC Therapies

One Biosciences receives Paris Saclay Cancer Cluster BOOST funding to advance a single-cell assay approach for antibody-drug conjugate therapies. More...
26 Jun 2026
Image: The study identified an unexpected immune signature in active TB, showing that disease is marked not by a weak immune response but by a distinct inflammatory profile (Photo courtesy of Shutterstock)

Airway Immune Signature May Predict Tuberculosis Progression Risk

New findings map airway immune signatures that predict TB progression versus control. More...
26 Jun 2026
Image Credit: Shutterstock

Ultrasensitive ctDNA Assay Detects MRD in Breast, Colorectal, Renal Cancers

Myriad Genetics has expanded availability of Precise MRD to treatment and surveillance for breast, colorectal, and renal cancers.  More...
26 Jun 2026
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Benchtop Thermomixer
Biometra TS1 ThermoShaker
HPV Test
Allplex HPV28 Detection
ADLM